Article
Using the eosin‐5‐maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis
2 May 2008
Abstract excerpt
BACKGROUND: Flow cytometric analysis of eosin-5-maleimide (EMA)-labeled red blood cells (RBCs) has been used as a screening test for the diagnosis of patients with hereditary spherocytosis (HS). We assessed the fluorescence profiles for patients having HS and hereditary pyropoikilocytosis (HPP) together with their red cell indices. METHODS: Flow cytometry was used to analyze EMA-labeled RBCs. Membrane protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
